Joanne E. Nettleship

Joanne E. Nettleship

Auto-generated profile, based on publicly available information

Joanne E. Nettleship

The Oxford Protein Production Facility, Henry Wellcome Building for Genomic Medicine, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2007 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
NBNick S. Berrow
Nick S. Berrow
DADavid Alderton
David Alderton
SSSarah Sainsbury
Sarah Sainsbury
JNJoanne Nettleship
Joanne Nettleship
RARene Assenberg
Rene Assenberg
Ray OwensRay Owens
Ray Owens
This article describes the construction of a set of versatile expression vectors based on the In-Fusion™ cloning enzyme and their use for high-throughput cloning and expression screening. Modifications to commonly used vectors rendering them compatible with In-Fusion™ has produced a ligation-independent cloning system that is (1) insert sequence independent (2) capable of cloning large PCR fragments (3) efficient over a wide (20-fold) insert concentration range and (4) applicable to expression in multiple hosts. The system enables the precise engineering of (His6-) tagged constructs with no undesirable vector or restriction-site-derived amino acids added to the expressed protein. The use of a multiple host-enabled vector allows rapid screening in both E. coli and eukaryotic hosts (HEK293T cells and insect cell hosts, e.g. Sf9 cells). These high-throughput screening activities have prompted the development and validation of automated protocols for transfection of mammalian cells and Ni-NTA protein purification.

1 March 2007 in Structure
Verified
Journal Article
Open access
VCVeronica T. Chang
Veronica T. Chang
MCMax Crispin
Max Crispin
AAA. Radu Aricescu
A. Radu Aricescu
DHDavid J. Harvey
David J. Harvey
JNJoanne E. Nettleship
Joanne E. Nettleship
SDSimon J. Davis
Simon J. Davis
Glycoproteins present special problems for structural genomic analysis because they often require glycosylation in order to fold correctly, whereas their chemical and conformational heterogeneity generally inhibits crystallization. We show that the "glycosylation problem" can be solved by expressing glycoproteins transiently in mammalian cells in the presence of the N-glycosylation processing inhibitors, kifunensine or swainsonine. This allows the correct folding of the glycoproteins, but leaves them sensitive to enzymes, such as endoglycosidase H, that reduce the N-glycans to single residues, enhancing crystallization. Since the scalability of transient mammalian expression is now comparable to that of bacterial systems, this approach should relieve one of the major bottlenecks in structural genomic analysis.

1 November 2006 in Structure
Verified
Journal Article
Closed access
TWThomas S. Walter
Thomas S. Walter
CMChristoph Meier
Christoph Meier
RARene Assenberg
Rene Assenberg
KAKin-Fai Au
Kin-Fai Au
JRJingshan Ren
Jingshan Ren
JGJonathan M. Grimes
Jonathan M. Grimes

27 June 2017 in eLife
Verified
Journal Article
Open access
CTChristian Tiede
Christian Tiede
RBRobert Bedford
Robert Bedford
SHSophie J Heseltine
Sophie J Heseltine
GSGina Smith
Gina Smith
IWImeshi Wijetunga
Imeshi Wijetunga
DTDarren Charles Tomlinson
Darren Charles Tomlinson
Molecular recognition reagents are key tools for understanding biological processes and are used universally by scientists to study protein expression, localisation and interactions. Antibodies remain the most widely used of such reagents and many show excellent performance, although some are poorly characterised or have stability or batch variability issues, supporting the use of alternative binding proteins as complementary reagents for many applications. Here we report on the use of Affimer proteins as research reagents. We selected 12 diverse molecular targets for Affimer selection to exemplify their use in common molecular and cellular applications including the (a) selection against various target molecules; (b) modulation of protein function in vitro and in vivo; (c) labelling of tumour antigens in mouse models; and (d) use in affinity fluorescence and super-resolution microscopy. This work shows that Affimer proteins, as is the case for other alternative binding scaffolds, represent complementary affinity reagents to antibodies for various molecular and cell biology applications.

25 March 2014 in Protein Engineering, Design and Selection
Verified
Journal Article
Open access
PDF file
CTChristian Tiede
Christian Tiede
ATAnna Ah-San Tang
Anna Ah-San Tang
SDSarah E. Deacon
Sarah E. Deacon
UMUpasana Mandal
Upasana Mandal
JNJoanne E. Nettleship
Joanne E. Nettleship
MMMichael McPherson
Michael McPherson
We have designed a novel non-antibody scaffold protein, termed Adhiron, based on a phytocystatin consensus sequence. The Adhiron scaffold shows high thermal stability (Tm ca. 101°C), and is expressed well in Escherichia coli. We have determined the X-ray crystal structure of the Adhiron scaffold to 1.75 Å resolution revealing a compact cystatin-like fold. We have constructed a phage-display library in this scaffold by insertion of two variable peptide regions. The library is of high quality and complexity comprising 1.3 × 1010 clones. To demonstrate library efficacy, we screened against the yeast Small Ubiquitin-like Modifier (SUMO). In selected clones, variable region 1 often contained sequences homologous to the known SUMO interactive motif (V/I-X-V/I-V/I). Four Adhirons were further characterised and displayed low nanomolar affinities and high specificity for yeast SUMO with essentially no cross-reactivity to human SUMO protein isoforms. We have identified binders against >100 target molecules to date including as examples, a fibroblast growth factor (FGF1), platelet endothelial cell adhesion molecule (PECAM-1; CD31), the SH2 domain Grb2 and a 12-aa peptide. Adhirons are highly stable and well expressed allowing highly specific binding reagents to be selected for use in molecular recognition applications.

1 January 2008
Verified
Book Chapter
Closed access
PDF file
JNJoanne E. Nettleship
Joanne E. Nettleship
JBJames Brown
James Brown
MGMatthew Groves
Matthew Groves
AGArie Geerlof
Arie Geerlof